Paxlovid is startlingly expensive. As with many drugs in the United States, its pricing deserves renewed scrutiny. Among a handful of approved anti-retrovirals, the drug is the go-to prescription medicine to treat mild-to-moderate COVID-19 in adults. It can reduce the likelihood of ending up in the hospital for people at elevated risk. For older people… Read More »
This post was originally published on KFF Health News. It is published with open permission by that site. Measles is on the rise in the United States. In the first quarter of this year, the number of cases was about 17 times what it was, on average, during the same period in each of the four… Read More »
The 2022 midterm elections are upon us. And public health is once again prominent on the ballot. Think back to the 2020 presidential election and just how stark a contrast Joe Biden and Donald Trump presented on COVID-19, climate change, and the Affordable Care Act. This year is no different. Voters across the country are choosing… Read More »